Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECTOPIC/MUTAS Lung Cancer Biomarker Study
NCT02853006Completed
- Sponsor
- CHU Grenoble Alpes
- Start
- Jun 2015
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by CHU Grenoble Alpes. Primary endpoints: Quantification of DNA and Quantification of RNA. Started Jun 2015; status: completed.
Beyond the preview
Go deeper on NCT02853006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02853006.